Azitra (AZTR) Payables (2022 - 2026)

Azitra (AZTR) reported Payables of $932217.0 for Q1 2026, up 66.79% on a YoY basis from $558924.0 in Q1 2025, and up 133.43% quarter-over-quarter from $399356.0 in Q4 2025.

Azitra (AZTR) Payables (2022 - 2026) Analysis & Trends

Azitra has reported Payables for 5 years, with the latest figure at $932217.0 in Q1 2026.

  • For the quarter ending Q1 2026, Payables rose 66.79% year-over-year to $932217.0; the trailing twelve-month figure through Mar 2026 stood at $932217.0 (up 66.79% YoY), and the FY2025 full-year result was $399356.0, down 18.54% from the prior year.
  • Payables for Q1 2026 stood at $932217.0, up from $399356.0 in the prior quarter.
  • The five-year high for Payables was $996700.0 in Q2 2024, with the low at $364183.0 in Q2 2023.
  • Historically, Payables has averaged $643642.7 across 5 years, with a median of $588460.0 in 2024.
  • The largest YoY upside for Payables was 173.68% in 2024 against a maximum downside of 45.36% in 2024.
  • Azitra's Payables stood at $784687.0 in 2022, then gained by 14.35% to $897272.0 in 2023, then tumbled by 45.36% to $490255.0 in 2024, then fell by 18.54% to $399356.0 in 2025, then soared by 133.43% to $932217.0 in 2026.
  • The last three Payables figures came in at $932217.0 (Q1 2026), $399356.0 (Q4 2025), and $718476.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1.05 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 300,549.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 83.00 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 8.69 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 489.30 Mn
9 Abivax 91.96 Bn 91.96 Bn - 34.55 Mn
10 Azitra 20,900.00 20,900.00 - 932,217.00

Historic Data

Download Data
DateValue
Mar 31, 2026 932,217.00
Dec 31, 2025 399,356.00
Sep 30, 2025 718,476.00
Jun 30, 2025 635,842.00
Mar 31, 2025 558,924.00
Dec 31, 2024 490,255.00
Sep 30, 2024 588,460.00
Jun 30, 2024 996,700.00
Mar 31, 2024 583,055.00
Dec 31, 2023 897,272.00
Sep 30, 2023 417,928.00
Jun 30, 2023 364,183.00
Dec 31, 2022 784,687.00